Edit |   |
---|---|
Antigenic Specificity | C5, Human (Eculizumab biosimilar) |
Clone | Eculizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG2-G4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, FCM, IP, FuncS, IF, Neut |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human C5 Recombinant Antibody (Eculizumab). Eculizumab, sold under the brand name Soliris among others, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and neuromyelitis optica. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. |
Immunogen | n/a |
Other Names | Anti-C5 Recombinant Antibody, Research Grade Eculizumab, Anti-Human C5 Recombinant Antibody(Eculizumab), 5G1.1, h5G1.1HuG2/G4, Antibody Drug Analogues, Monoclonal Antibody, YR1003, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 219685-50-4 |
Catalog # | YR1003 |
Price | please inquire |
Order / More Info | C5, Human (Eculizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |